Navigation Links
Orchid Cellmark Reports Fourth Quarter and Full Year 2008 Financial Results
Date:3/16/2009

revenues 11 33 230 255 Total revenues 12,972 14,981 57,595 60,303 Operating expenses: Cost of service revenues 9,128 10,451 40,287 40,230 Research and development 192 213 846 1,045 Marketing and sales 1,201 1,521 5,860 6,021 General and administrative 3,437 3,638 16,076 15,385 Restructuring - - - (75) Amortization of intangible assets 466 469 1,895 1,806 Total operating expenses 14,424 16,292 64,964 64,412 Operating loss (1,452) (1,311) (7,369) (4,109) Other income, net 334 345 1,180 1,162 Loss before income tax expense (1,118) (966) (6,189) (2,947) Income tax expense (benefit) (1,591) (1,134) (1,708) 20 Net income (loss) $473 $168 $(4,481) $(2,967) Basic and diluted net income (loss) per share $0.02 $0.01 $(0.15) $(0.10) Shares used in computing basic net income (loss) per share: 29,935 29,711 29,935 29,583 Shares used in computing diluted net income (loss) per share: 29,935 29,810 29,935 29,583 Orchid Cellmark Inc. and Subsidiaries Condensed Consolidated Balance Sheets December 31, 2008 and December 31, 2007 (In thousands) (Unaudited) De
'/>"/>
SOURCE Orchid Cellmark Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Orchid Cellmark to Announce Fourth Quarter and Year-End 2008 Financial Results on March 16, 2009
2. Orchid Cellmark Reports Third Quarter 2008 Financial Results
3. Orchid Cellmark Reports Second Quarter 2008 Financial Results
4. Orchid Cellmark To Announce Second Quarter 2008 Financial Results on July 31, 2008
5. Orchid Cellmark Reports First Quarter 2008 Financial Results
6. Orchid Cellmark to Open a New Forensic Facility in the United Kingdom to Meet Increasing Demand for Its Services
7. Orchid Cellmark Reports Fourth Quarter and Full Year 2007 Financial Results
8. Orchid Cellmark to Announce Fourth Quarter and Full Year 2007 Financial Results on March 6, 2008
9. Orchid Cellmark Appoints William J. Thomas Vice President and General Counsel
10. Orchid Cellmark Reports Third Quarter 2007 Financial Results
11. Haemacure Reports First Quarter 2009 Results and Hires Advisor for the Sale or Merger of the Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Névo takes a bold step forward ... adding advanced activity tracking and phone notifications for a ... calories burned, and more. , http://www.nevowatch.com , ... habits in their busy lives to look and feel ... produce healthy results, but until now, style played a ...
(Date:9/23/2014)... Medicine in Motion (MIM) is proud to announce ... W. 38th, Suite G4. After serving the area’s sports medicine ... demand for MIM’s superior care led to the need for ... excited about bringing our high-quality brand of sports medicine to ... Motion. “We’ll continue to provide patients with the same great ...
(Date:9/22/2014)... 2014 The Gesundheit! Institute founded ... design and restructuring for their existing website. The Institute had ... needed a way to navigate to the different branches of ... present the look and feel of the site in a ... when Patch Adams graduated from The Medical School of Virginia, ...
(Date:9/22/2014)... Provo, Utah (PRWEB) September 23, 2014 ... education and corporate training, will be attending and ... of the American Health Information Management Association (AHIMA) ... held September 27 through October 1, and Career ... information on its suite of coding training products, ...
(Date:9/22/2014)... During the annual Oregon Health Care Association ... care and senior housing industry are recognized for their ... of others. , This year, Nicolette Merino, Regional ... awarded the OHCA Special Service Award. This award is ... assist OHCA in reaching strategic objectives or help achieve ...
Breaking Medicine News(10 mins):Health News:Nevo changes the face of fitness wearables with an analogue watch combining activity tracking, phone notifications, and LED goal progress indicators for active lifestyles 2Health News:Nevo changes the face of fitness wearables with an analogue watch combining activity tracking, phone notifications, and LED goal progress indicators for active lifestyles 3Health News:Austin Sports Medicine Practice to Host Grand Opening Event for Second Location 2Health News:Idea Marketing Group Launches a New Website for The Gesundheit! Institute 2Health News:Idea Marketing Group Launches a New Website for The Gesundheit! Institute 3Health News:Career Step to Exhibit at AHIMA Convention September 27 through October 1 2Health News:Avamere Family of Companies Regional Director Nominated for the Oregon Health Care Association 2014 Special Service Award 2
... Jose "El Nino" Temprana, a 105-year-old exile who was detained for ... when he became a US citizen at a ceremony in Miami. ... find himself a wife. ,And the former fisherman is ... once plotted to assassinate. ,"He's far less healthy than ...
... about it for fourteen years and when he finally started it ... Ark. ,Huibers, a jovial man with a smile ... after having a dream that the Netherlands was flooded. ... I like to talk about God and tell the story," Huibers ...
... your pet could prove bad for your lungs. ... from the cats skin could irritate the lungs and exacerbate ... specific allergy to the animals. Of course the problem is ... kind or another. ,A Europe-wide study by a ...
... visits to hospitals and doctors, new data suggests . ... of increased birth rates, such as those during the economic ... have put the generation's birth years at 1946 to 1964. ... booming, prosperous America, admired and envied by other countries. ...
... issue of The American Journal of Medicine, researchers from ... that people 45 to 64 years of age who ... for cardiovascular disease (CVD) and reduce their death rate. ... eating at least 5 fruits and vegetables daily, exercising ...
... Jammu and Kashmir has allegedly committed suicide in her home ... Razdan of the Engineering Regiment was found hanging by her ... quarters at Kunjwani on the outskirts of this winter capital ... a nearby market area and found the door locked from ...
Cached Medicine News:Health News:The American Dream Comes True for 105-year-old Cuban 2Health News:Dutchman Rebuilds Noah's Ark to Spread His Faith 2Health News:Dutchman Rebuilds Noah's Ark to Spread His Faith 3Health News:Allergic Individuals Should Keep Away from Cats, Say UK Scientists 2Health News:Allergic Individuals Should Keep Away from Cats, Say UK Scientists 3Health News:As the US Population Ages, Hospital and Doctors Visits Shoot Up 2Health News:Healthy Lifestyle can Reduce Cardiovascular Risk 2
(Date:9/22/2014)... , Sept. 22, 2014  Elusys Therapeutics, ... to treat infectious disease, today announced it has ... studies of obiltoxaximab (ETI-204). Obiltoxaximab is an anti-toxin ... and data from these studies support the safety ... (IV) at the intended therapeutic dose. The conclusion ...
(Date:9/22/2014)...  Aethlon Medical, Inc. (OTCQB: AEMD), the pioneer ... disease, cancer and other life-threatening conditions, disclosed today ... has informed the Company that it plans to ... of a five-year $5.9 million contract that was ... DARPA,s Dialysis-Like Therapeutics (DLT) program. The ...
(Date:9/22/2014)... 2014 /CNW/ - T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" or ... quality medical marijuana products, is pleased to announce that ... signed a definitive lease agreement for a second facility ... facility has 28,966 square feet of floor space with ... mezzanine space for a total of approximately 43,500 square ...
Breaking Medicine Technology:Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 2Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 3Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 4Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 5Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 6Aethlon Medical Receives Notice of DARPA Contract Renewal 2Aethlon Medical Receives Notice of DARPA Contract Renewal 3Aethlon Medical Receives Notice of DARPA Contract Renewal 4T-Bird Pharma Inc. to Increase Growing Capacity with Expansion into a 43,500 square feet Second Facility 2T-Bird Pharma Inc. to Increase Growing Capacity with Expansion into a 43,500 square feet Second Facility 3
...  PAREXEL International Corporation (NASDAQ: PRXL ) today ... March 31, 2012. For the three months ... by 18.1% to $356.0 million compared with $301.4 million ... negative impact from foreign exchange on consolidated service revenue ...
... Mass., April 29, 2012  Haemonetics Corporation (NYSE: ... acquire the business assets of the blood collection, filtration ...  Blood processing systems and equipment to be acquired are ... facilities in Covina, California; Tijuana, Mexico; Ascoli, Italy and ...
Cached Medicine Technology:PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 2PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 3PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 4PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 5PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 6PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 7PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 8PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 9PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 10PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 11PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 12PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results 13Haemonetics Signs Definitive Agreement to Acquire Pall Corporation's Blood Collection, Filtration and Processing Product Lines For $551 Million 2Haemonetics Signs Definitive Agreement to Acquire Pall Corporation's Blood Collection, Filtration and Processing Product Lines For $551 Million 3Haemonetics Signs Definitive Agreement to Acquire Pall Corporation's Blood Collection, Filtration and Processing Product Lines For $551 Million 4Haemonetics Signs Definitive Agreement to Acquire Pall Corporation's Blood Collection, Filtration and Processing Product Lines For $551 Million 5
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: